FinnGen: ensimmäinen vuosi takana – mitä seuraavaksi?

FinnGen hankkeen toinen yrityksille suunnattu infotilaisuus järjestettiin perjantaina 9.11.2018 Team Finland –talossa Helsingissä.

Tilaisuuden esitykset löytyvät alla olevasta ohjelmasta kuhunkin puheenvuoroon linkitettyinä.

Ohjelma:

9:30 - 10.00

Kahvitarjoilu

10:00 - 10:05

Tilaisuuden avaus

Eero Punkka, Helsingin Biopankki

10:05 - 10:50

FinnGen tilannekatsaus

Aarno Palotie, Helsingin yliopisto

10:50 - 11:30

Pharma’s expectations from FinnGen: Pfizer as an example

Jaakko Parkkinen, Pfizer

11:30 - 12:00

Palveluoperaattori - ekosysteemiä rakentamaan

Hannu Hämäläinen, Sitra

FinnGen in brief

FinnGen is a large public-private partnership aiming to collect and analyse genome and health data from 500,000 Finnish biobank participants. FinnGen aims on one hand to provide novel medically and therapeutically relevant insights but also construct a world-class resource that can be applied for future studies.

FinnGen is one of the very first personalized medicine projects at this scale and the public-private collaborative nature of the project is exceptional compared to many ongoing studies. FinnGen brings together Finnish universities, hospitals and hospital districts, THL, Blood Service, biobanks, FINBB and international pharmaceutical companies and hundreds of thousands of Finns. Because collaboration is the key to achieving breakthroughs in disease prevention, diagnosis, and treatment, we welcome everyone on this journey into our shared heritage.